eglumetad has been researched along with Panic Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlt, J; Kellner, M; Muhtz, C; Stark, K; Wiedemann, K; Yassouridis, A | 1 |
| Bergink, V; Westenberg, HG | 1 |
2 trial(s) available for eglumetad and Panic Disorder
| Article | Year |
|---|---|
Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
Topics: Adrenocorticotropic Hormone; Adult; Anxiety; Bridged Bicyclo Compounds; Cross-Over Studies; Double-Blind Method; Excitatory Amino Acid Agonists; Humans; Hydrocortisone; Male; Panic Disorder; Prolactin; Receptors, Metabotropic Glutamate; Tetragastrin | 2005 |
Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740.
Topics: Adult; Anti-Anxiety Agents; Bridged Bicyclo Compounds; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Receptors, Metabotropic Glutamate; Selective Serotonin Reuptake Inhibitors | 2005 |